Systemic nitroglycerin activates peptidergic and catecholaminergic pathways in rat brain

Area of Science:

• Neuroscience
• Pharmacology
• Neurochemistry

Background:

• Nitroglycerin is a vasodilator used to treat angina.
• Its central nervous system effects, particularly on neuronal activation, are not fully understood.
• Understanding these pathways is crucial for managing nitroglycerin's side effects and potential therapeutic applications.

Purpose of the Study:

• To investigate the neurochemical profile of neurons activated by systemic nitroglycerin administration.
• To identify specific neurotransmitter systems and brain regions involved in the response to nitroglycerin.

Main Methods:

• Immunohistochemistry was used to detect Fos protein expression, indicating neuronal activation.
• Co-localization studies identified neurotransmitters (noradrenaline, serotonin) and neuropeptides (vasopressin, oxytocin, corticotropin-releasing factor) in activated neurons.
• Brain regions examined included the brainstem, hypothalamus, and amygdala.

Main Results:

• A significant proportion of activated neurons in the brainstem utilized noradrenaline.
• Few activated neurons in the brainstem contained serotonin.
• Numerous activated neurons in the hypothalamus (paraventricular and supraoptic nuclei) and amygdala (central nucleus) expressed vasopressin, oxytocin, and corticotropin-releasing factor.

Conclusions:

• Systemic nitroglycerin prominently activates catecholaminergic pathways in the brainstem.
• Peptidergic systems, including those involving vasopressin, oxytocin, and corticotropin-releasing factor, are significantly involved in the central response to nitroglycerin.
• These findings elucidate the role of specific neurochemical pathways in mediating the central effects of nitroglycerin.